# Comgest Growth Europe ex Switzerland
## SCHEDULE OF INVESTMENTS
As at 30 June 2020 (expressed in CHF)
| Quantity/ Security	Face value | Currency | Acquisition cost CHF | Fair Value CHF | % Net Assets |
| --- | --- | --- | --- | --- |
|  |  |  |  |  |
| Equity securities |  | 99,652,647 | 119,034,184 | 90.34 |

| Transferable securities admitted to an official stock exchange listing | 99,652,647 | 119,034,184	90.34 |
| --- | --- | --- |
| Other transferable securities |  |  |
| Equity securities |  |  |
| Italy |  |  |
| Pharmaceuticals and cosmetics Amplifon SpA - Interim B | 116,996 | EUR | 2,179,135 | 2,952,178 | 2.24 |
|  |  |  | 2,179,135 | 2,952,178 | 2.24 |
|  |  |  |  |  |  |
| Total Italy |  |  | 2,179,135 | 2,952,178 | 2.24 |
|  |  |  |  |  |  |
| Equity securities |  |  | 2,179,135 | 2,952,178 | 2.24 |
|  |  |  |  |  |  |
| Other transferable securities |  |  | 2,179,135 | 2,952,178 | 2.24 |
|  |  |  |  |  |  |
| Financial assets at fair value through profit or loss |  |  | 101,831,782 | 121,986,362 | 92.58 |
| Total financial derivative instrument (Note 6) |  |  |  | (932,765) | (0.71) |
| Cash and other net assets | 	10,717,261	8.13  |
| Total net assets attributable to holders of redeemable participating shares |   131,770,858	100.00  |
|  | % of Total Assets |
| Transferable securities admitted to an official stock exchange listing | 90.33 |
| Other transferable securities | 2.24 |
| Derivative instrument | 0.36 |

| Comgest Growth Europe ex UK |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- |
| SCHEDULE OF INVESTMENTS As at 30 June 2020 (expressed in GBP) |  |  |  |  |  |
| Security | Quantity/ Face value | Currency | Acquisition cost GBP | Fair Value GBP | % Net Assets |
| Financial assets at fair value through profit and loss |  |  |  |  |  |

Transferable securities admitted to an official stock exchange listing Equity securities
Denmark
Biotechnology
| Chr Hansen Holding A/S | 21,051 | DKK | 1,344,011 | 1,756,091 | 1.40 |
| --- | --- | --- | --- | --- | --- |
|  |  |  | 1,344,011 | 1,756,091 | 1.40 |
| Internet software SimCorp A/S | 28,893 | DKK | 1,998,078 | 2,519,514 | 2.02 |
|  |  |  | 1,998,078 | 2,519,514 | 2.02 |
| Pharmaceuticals and cosmetics Ambu A/S | 65,540 | DKK | 929,968 | 1,665,798 | 1.33 |
| Coloplast A/S - B Shares | 9,048 | DKK | 774,797 | 1,134,394 | 0.91 |
| Novo Nordisk A/S - B Shares | 116,531 | DKK | 4,843,196 | 6,102,694 | 4.88 |
|  |  |  | 6,547,961 | 8,902,886 | 7.12 |
|  |  |  |  |  |  |
| Total Denmark |  |  | 9,890,050 | 13,178,491 | 10.54 |
| France |  |  |  |  |  |
| Healthcare education and social services Orpea | 44,133 | EUR | 4,163,496 | 4,127,990 | 3.30 |
|  |  |  | 4,163,496 | 4,127,990 | 3.30 |
| Internet software Dassault Systèmes SE | 28,213 | EUR | 3,271,603 | 3,939,130 | 3.15 |
|  |  |  | 3,271,603 | 3,939,130 | 3.15 |
| News transmission Teleperformance | 5,859 | EUR | 1,023,303 | 1,203,094 | 0.96 |
|  |  |  | 1,023,303 | 1,203,094 | 0.96 |
| Pharmaceuticals and cosmetics EssilorLuxottica SA | 51,162 | EUR | 5,481,563 | 5,313,291 | 4.25 |
| L'Oreal SA | 15,645 | EUR | 3,111,283 | 4,062,989 | 3.25 |
| Sartorius Stedim Biotech | 5,420 | EUR | 573,267 | 1,108,515 | 0.89 |
|  |  |  | 9,166,113 | 10,484,795 | 8.39 |

Translation (ENDE, 2020-06-30):
# Comgest Growth Europe ex Switzerland
WESENTLICHE BESTANDSVERÄNDERUNGEN für den Berichtszeitraum zum 30. Juni 2020
| Käufe |  |  |  |
| --- | --- | --- | --- |
| Prozentualer Anteil |
| Wertpapier | Stück | Betrag (CHF) | Käufe |
| MTU Aero Engines AG | 17.384 | 3.533.039 | 14,26 |
| Associated British Foods PLC | 81.660 | 2.802.668 | 11,31 |
| Jeronimo Martins SGPS SA | 156.179 | 2.611.466 | 10,54 |
| Ferrari NV | 15.018 | 2.059.481 | 8,31 |
| SimCorp A/S | 23.144 | 2.030.922 | 8,20 |
| Orpea | 15.771 | 1.950.762 | 7,87 |
| Davide Campari-Milano SpA | 199.541 | 1.811.104 | 7,31 |
| Teleperformance | 8.787 | 1.765.516 | 7,13 |
| Adyen NV | 1.787 | 1.429.306 | 5,77 |
| Heineken NV | 11.303 | 1.159.392 | 4,68 |
| B&M European Value Retail SA | 335.361 | 1.119.103 | 4,52 |
| Amadeus IT Group SA – A-Aktien | 12.768 | 571.385 | 2,31 |
| ICON PLC | 2.500 | 416.998 | 1,68 |
| LVMH Moët Hennessy Louis Vuitton SE | 1.140 | 373.861 | 1,51 |
| Unilever NV | 4.678 | 238.703 | 0,96 |
| ASML Holding NV | 800 | 187.237 | 0,76 |
| EssilorLuxottica SA | 1.698 | 179.175 | 0,72 |
| Dassault Systèmes SE | 1.299 | 171.360 | 0,69 |
| Ryanair Holdings PLC | 10.998 | 144.689 | 0,58 |
| Accenture PLC | 719 | 111.756 | 0,45 |

| Verkäufe 1 |  |  |  |
| --- | --- | --- | --- |
| Prozentualer Anteil |
| Wertpapier | Stück | Betrag (CHF) | Verkäufe |
| Sartorius Stedim Biotech | 19.743 | 3.833.290 | 20,05 |
| Coloplast A/S – B-Aktien | 22.811 | 2.917.058 | 15,26 |
| Fresenius SE & Co KGaA | 47.523 | 2.234.893 | 11,69 |
| Ambu A/S | 65.203 | 1.716.038 | 8,98 |
| Edenred | 40.500 | 1.630.075 | 8,53 |
| Genmab A/S | 8.842 | 1.623.724 | 8,49 |
| Chr Hansen Holding A.S | 10.969 | 785.908 | 4,11 |
| Eurofins Scientific SE | 1.059 | 672.162 | 3,52 |
| Novo Nordisk A/S – B-Aktien | 12.713 | 663.206 | 3,47 |
| GRENKE AG | 12.298 | 599.557 | 3,14 |
| Rightmove PLC | 96.150 | 493.467 | 2,58 |
| Jeronimo Martins SGPS SA | 29.158 | 459.382 | 2,40 |
| Dassault Systèmes SE | 2.378 | 408.003 | 2,13 |
| Experian PLC | 12.160 | 407.283 | 2,13 |
| MTU Aero Engines AG | 1.327 | 405.182 | 2,12 |
| LVMH Moët Hennessy Louis Vuitton SE | 629 | 270.268 | 1,40 |

1 Steht für die gesamten Verkäufe im Berichtszeitraum.